Unknown

Dataset Information

0

Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.


ABSTRACT: Cancer anorexia-cachexia syndrome is characterized by decreased food intake, weight loss, muscle tissue wasting and psychological distress, and this syndrome is a major source of increased morbidity and mortality in cancer patients. This study aimed to clarify the gut-brain peptides involved in the pathogenesis of the syndrome and determine effective treatment for cancer anorexia-cachexia. We show that both ghrelin insufficiency and resistance were observed in tumor-bearing rats. Corticotropin-releasing factor (CRF) decreased the plasma level of acyl ghrelin, and its receptor antagonist, ?-helical CRF, increased food intake of these rats. The serotonin 2c receptor (5-HT2cR) antagonist SB242084 decreased hypothalamic CRF level and improved anorexia, gastrointestinal (GI) dysmotility and body weight loss. The ghrelin receptor antagonist (D-Lys3)-GHRP-6 worsened anorexia and hastened death in tumor-bearing rats. Ghrelin attenuated anorexia-cachexia in the short term, but failed to prolong survival, as did SB242084 administration. In addition, the herbal medicine rikkunshito improved anorexia, GI dysmotility, muscle wasting, and anxiety-related behavior and prolonged survival in animals and patients with cancer. The appetite-stimulating effect of rikkunshito was blocked by (D-Lys3)-GHRP-6. Active components of rikkunshito, hesperidin and atractylodin, potentiated ghrelin secretion and receptor signaling, respectively, and atractylodin prolonged survival in tumor-bearing rats. Our study demonstrates that the integrated mechanism underlying cancer anorexia-cachexia involves lowered ghrelin signaling due to excessive hypothalamic interactions of 5-HT with CRF through the 5-HT2cR. Potentiation of ghrelin receptor signaling may be an attractive treatment for anorexia, muscle wasting and prolong survival in patients with cancer anorexia-cachexia.

SUBMITTER: Fujitsuka N 

PROVIDER: S-EPMC3309517 | biostudies-literature | 2011 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.

Fujitsuka N N   Asakawa A A   Uezono Y Y   Minami K K   Yamaguchi T T   Niijima A A   Yada T T   Maejima Y Y   Sedbazar U U   Sakai T T   Hattori T T   Kase Y Y   Inui A A  

Translational psychiatry 20110726


Cancer anorexia-cachexia syndrome is characterized by decreased food intake, weight loss, muscle tissue wasting and psychological distress, and this syndrome is a major source of increased morbidity and mortality in cancer patients. This study aimed to clarify the gut-brain peptides involved in the pathogenesis of the syndrome and determine effective treatment for cancer anorexia-cachexia. We show that both ghrelin insufficiency and resistance were observed in tumor-bearing rats. Corticotropin-r  ...[more]

Similar Datasets

| S-EPMC7432590 | biostudies-literature
| S-EPMC9035074 | biostudies-literature
| S-EPMC5700099 | biostudies-literature
| S-EPMC10995265 | biostudies-literature
| S-EPMC5078860 | biostudies-other
2017-10-01 | GSE104155 | GEO
| S-EPMC4248409 | biostudies-literature
| S-EPMC6491219 | biostudies-literature
| S-EPMC5029183 | biostudies-literature
| S-EPMC4121852 | biostudies-literature